Search Results - "Duru, A. D."

Refine Results
  1. 1
  2. 2

    The use of novel drugs can effectively improve response, delay relapse and enhance overall survival in multiple myeloma patients with renal impairment by Uttervall, Katarina, Duru, Adil D, Lund, Johan, Liwing, Johan, Gahrton, Gösta, Holmberg, Erik, Aschan, Johan, Alici, Evren, Nahi, Hareth

    Published in PloS one (08-07-2014)
    “…Renal impairment is a common feature in multiple myeloma and is considered a poor prognostic factor. To determine the impact of novel drugs (i.e. bortezomib,…”
    Get full text
    Journal Article
  3. 3

    Unexpected T‐cell recognition of an altered peptide ligand is driven by reversed thermodynamics by Allerbring, Eva B., Duru, Adil D., Uchtenhagen, Hannes, Madhurantakam, Chaithanya, Tomek, Markus B., Grimm, Sebastian, Mazumdar, Pooja A., Friemann, Rosmarie, Uhlin, Michael, Sandalova, Tatyana, Nygren, Per‐Åke, Achour, Adnane

    Published in European journal of immunology (01-11-2012)
    “…The molecular basis underlying T‐cell recognition of MHC molecules presenting altered peptide ligands is still not well–established. A hierarchy of T‐cell…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity by Dahlberg, Carin I M, Sarhan, Dhifaf, Chrobok, Michael, Duru, Adil D, Alici, Evren

    Published in Frontiers in immunology (2015)
    “…Natural killer (NK) cells were discovered 40 years ago, by their ability to recognize and kill tumor cells without the requirement of prior antigen exposure…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Characterization of zika virus infection of human fetal cardiac mesenchymal stromal cells by Rossi, Fiorella, Josey, Benjamin, Sayitoglu, Ece Canan, Potens, Renee, Sultu, Tolga, Duru, Adil Doganay, Beljanski, Vladimir

    Published in PloS one (17-09-2020)
    “…Zika virus (ZIKV) is a single-stranded RNA virus belonging to the family Flaviviridae. ZIKV predominantly enters cells using the TAM-family protein tyrosine…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Identification and strategic targeting of key anti-viral defense mechanisms in Natural Killer cells by Sayitoglu, Ece Canan, Ozkazanc, Didem, Sarac, Aydan, Parlar, Ayhan, Alici, Evren, Erman, Batu, Duru, Adil Doganay, Sutlu, Tolga

    Published in JOURNAL OF IMMUNOLOGY (01-05-2018)
    “…Abstract While genetic modification of lymphocytes proves to be an efficient approach in immunotherapy, commonly used lentiviral vectors are haunted by the…”
    Get full text
    Journal Article Conference Proceeding
  13. 13
  14. 14

    Tuning antiviral CD8 T-cell response via proline-altered peptide ligand vaccination by Duru, Adil Doganay, Sun, Renhua, Allerbring, Eva B, Chadderton, Jesseka, Kadri, Nadir, Han, Xiao, Peqini, Kaliroi, Uchtenhagen, Hannes, Madhurantakam, Chaithanya, Pellegrino, Sara, Sandalova, Tatyana, Nygren, Per-Åke, Turner, Stephen J, Achour, Adnane

    Published in PLoS pathogens (01-05-2020)
    “…Viral escape from CD8+ cytotoxic T lymphocyte responses correlates with disease progression and represents a significant challenge for vaccination. Here, we…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells by Chrobok, Michael, Dahlberg, Carin I M, Sayitoglu, Ece Canan, Beljanski, Vladimir, Nahi, Hareth, Gilljam, Mari, Stellan, Birgitta, Sutlu, Tolga, Duru, Adil Doganay, Alici, Evren

    Published in Cancers (01-01-2019)
    “…Natural killer (NK) cells stand out as promising candidates for cellular immunotherapy due to their capacity to kill malignant cells. However, the therapeutic…”
    Get full text
    Journal Article
  17. 17

    The MHC Class I Cancer-Associated Neoepitope Trh4 Linked with Impaired Peptide Processing Induces a Unique Noncanonical TCR Conformer by Hafstrand, Ida, Doorduijn, Elien M, Duru, Adil Doganay, Buratto, Jeremie, Oliveira, Claudia Cunha, Sandalova, Tatyana, van Hall, Thorbald, Achour, Adnane

    Published in The Journal of immunology (1950) (01-03-2016)
    “…MHC class I downregulation represents a significant challenge for successful T cell-based immunotherapy. T cell epitopes associated with impaired peptide…”
    Get full text
    Journal Article
  18. 18

    Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma by Duru, Adil Doganay, Sutlu, Tolga, Wallblom, Ann, Uttervall, Katarina, Lund, Johan, Stellan, Birgitta, Gahrton, Gösta, Nahi, Hareth, Alici, Evren

    Published in PloS one (17-09-2015)
    “…Loss of the chromosomal region 8p21 negatively effects survival in patients with multiple myeloma (MM) that undergo autologous stem cell transplantation…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Inflammation-associated nitrotyrosination affects TCR recognition through reduced stability and alteration of the molecular surface of the MHC complex by Madhurantakam, Chaithanya, Duru, Adil D, Sandalova, Tatyana, Webb, John R, Achour, Adnane

    Published in PloS one (14-03-2012)
    “…Nitrotyrosination of proteins, a hallmark of inflammation, may result in the production of MHC-restricted neoantigens that can be recognized by T cells and…”
    Get full text
    Journal Article